Post-marketing Surveillance Programs in the Pharmaceutical Sector: A Regulatory Tool for Ensuring Medicine Quality and Safety
Therapeutic Innovation & Regulatory Science · 19.11.2026
DOI: 10.1007/s43441-026-01078-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 19.11.2026. Verfasst von Naif D. Alenzi und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alenzi, N. D., Alsagoor, T. M., Alshammari, M. F., Ali, E. S., Alshehri, A. A., Alajmi, M., & Alrowaili, K. (2026). Post-marketing Surveillance Programs in the Pharmaceutical Sector: A Regulatory Tool for Ensuring Medicine Quality and Safety. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-026-01078-9
Vancouver
Alenzi ND, Alsagoor TM, Alshammari MF, Ali ES, Alshehri AA, Alajmi M, et al. Post-marketing Surveillance Programs in the Pharmaceutical Sector: A Regulatory Tool for Ensuring Medicine Quality and Safety. Therapeutic Innovation & Regulatory Science. 2026. doi:10.1007/s43441-026-01078-9
BibTeX
@article{Alenzi2026,
author = {Alenzi, Naif D. and Alsagoor, Turki M. and Alshammari, Munif F. and Ali, Emad S. and Alshehri, Abdullah A. and Alajmi, Mathed and Alrowaili, Kholoud},
title = {Post-marketing Surveillance Programs in the Pharmaceutical Sector: A Regulatory Tool for Ensuring Medicine Quality and Safety},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2026},
doi = {10.1007/s43441-026-01078-9}
}
EUVIMED